We are live on ! Find out more
KRRO icon

Korro Bio
KRRO

88 hedge funds and large institutions have $135M invested in Korro Bio in 2021 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 23 increasing their positions, 33 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more call options, than puts

Call options by funds: $1.54M | Put options by funds: $1.2M

0.05% less ownership

Funds ownership: 1.14% → 1.09% (-0.05%)

3% less funds holding

Funds holding: 91 → 88 (-3)

25% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 12

30% less repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 33

32% less capital invested

Capital invested by funds: $198M → $135M (-$63.3M)

Holders
88
Holders Change
-3
Holders Change %
-3.3%
% of All Funds
1.54%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
23
Reduced
33
Closed
12
Calls
$1.54M
Puts
$1.2M
Net Calls
+$334K
Net Calls Change
-$420K

Top Buyers

Rank Fund Capital Flow
1
Federated Hermes
Federated Hermes
Pennsylvania
+$4.13M
2
BlackRock
BlackRock
New York
+$953K
3
GCP
GSA Capital Partners
United Kingdom
+$643K
4
SDIC
South Dakota Investment Council
South Dakota
+$513K
5
Walleye Capital
Walleye Capital
New York
+$416K

Top Sellers

Rank Fund Capital Flow
1
Amundi
Amundi
France
-$3.93M
2
SFM
Sphera Funds Management
Israel
-$2.74M
3
Millennium Management
Millennium Management
New York
-$1.88M
4
Morgan Stanley
Morgan Stanley
New York
-$1.46M
5
JP Morgan Chase
JP Morgan Chase
New York
-$1.27M
Name Holding Trade Value Shares
Change 		Change in
Stake
TRCT
76
Tower Research Capital (TRC)
New York
$8K -$9.84K -25 -54%
BG
77
Bollard Group
Massachusetts
$8K – – –
UBS Group
78
UBS Group
Switzerland
$7K -$7.08K -18 -50%
PCM
79
Penserra Capital Management
California
$5K – – –
HFM
80
Hartford Financial Management
Connecticut
$4K – – –
Wells Fargo
81
Wells Fargo
California
$2K -$121K -307 -98%
US Bancorp
82
US Bancorp
Minnesota
$2K -$15K -38 -90%
CHA
83
Carmichael Hill & Associates
Maryland
$2K – – –
PNC Financial Services Group
84
PNC Financial Services Group
Pennsylvania
$1K +$787 +2 New
Walleye Capital
85
Walleye Capital
New York
$847 +$416K +1,057 +79%
KFS
86
Kelly Financial Services
Massachusetts
$494 -$5.12K -13 -93%
GFPC
87
Global Financial Private Client
Florida
$282 – – –
SFM
88
Sphera Funds Management
Israel
– -$2.74M -5,503 Closed
Millennium Management
89
Millennium Management
New York
– -$1.88M -3,776 Closed
IC
90
Ikarian Capital
Texas
– -$696K -1,398 Closed
BBA
91
Baker Bros. Advisors
New York
– -$553K -1,111 Closed
TA
92
TRB Advisors
New York
– -$471K -946 Closed
Manulife (Manufacturers Life Insurance)
93
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$197K -395 Closed
Squarepoint
94
Squarepoint
New York
– -$109K -218 Closed
Victory Capital Management
95
Victory Capital Management
Texas
– -$104K -209 Closed
Russell Investments Group
96
Russell Investments Group
United Kingdom
– -$73K -148 Closed
PGWM
97
Parisi Gray Wealth Management
New Jersey
– -$7K -14 Closed
FIA
98
FNY Investment Advisers
New York
– -$2K -5 Closed
ASN
99
Advisory Services Network
Georgia
– -$1K -2 Closed
1 2 3
4

KRRO Hedge Fund Activity: Q3 2021 in Review

88 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Korro Bio (KRRO) for Q3 2021, worth a combined $135M — down 32% from $198M a quarter earlier.

Sellers outnumbered buyers: 12 funds closed out of KRRO and 9 opened new positions — a net loss of 3 holders — while 33 trimmed existing stakes and 23 added.

The largest buyer was Federated Hermes, adding an estimated $4.13M. The largest seller was Amundi, cutting an estimated $3.93M.

  • 88 institutional investors held Korro Bio (KRRO) as of Q3 2021, down from 91 in Q2 2021.
  • Funds reported $135M of Korro Bio stock for Q3 2021, down 32% quarter-over-quarter.
  • 9 funds opened new Korro Bio positions in Q3 2021 and 12 closed out, a net change of -3 holders.
  • The largest Korro Bio buyer in Q3 2021 was Federated Hermes, an estimated $4.13M added.
  • The largest Korro Bio seller in Q3 2021 was Amundi, an estimated $3.93M sold.

Based on aggregated 13F filings for Q3 2021.